Opioid deaths, suicide drive down life expectancy
Life expectancy rates in the United States declined for the third year in a row as gains from heart disease and cancer treatment advances flattened and drug overdose and suicide rates rose. The average American can now expect to live 78.6 years, down from 78.7 years in 2016, according to the report from the National Center for Health Statistics. “Life expectancy gives us a snapshot of the nation’s overall health and these sobering statistics are a wakeup call that we are losin g too many Americans,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 30, 2018 Category: Pharmaceuticals Authors: Anne Stych Source Type: news

Morning Break: Measles Rebound; New FDA Warnings; Cancer Dx Scares
(MedPage Today) -- Health news and commentary from around the Web gathered by the MedPage Today staff (Source: MedPage Today Radiology)
Source: MedPage Today Radiology - November 30, 2018 Category: Radiology Source Type: news

Kenya: Kenya Seeks IAEA Help to Step Up Cancer Treatment
[Capital FM] Vienna -Kenya has sought the assistance of the International Atomic Energy Agency (IAEA) to step up treatment of cancer at its two referral hospitals and extend the services to the country's three other major towns. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 30, 2018 Category: African Health Source Type: news

Breast cancer increases the risk of osteoporosis
Research, published inBreast Cancer Research, suggests that women under 50 with breast cancer have an increased risk of developing osteoporosis.MedicalXpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 30, 2018 Category: Endocrinology Source Type: news

Curcumin: A major breakthrough in cancer prevention and treatment?
(Natural News) Turmeric has many uses around the world. Whether it’s being used as a spice in curries, as a natural food-based coloring agent or in medicine, this golden-hued root is up to the task. In Ayurvedic medicine, turmeric is prescribed for a number of ailments, including pain and inflammation. As Western science has begun... (Source: NaturalNews.com)
Source: NaturalNews.com - November 30, 2018 Category: Consumer Health News Source Type: news

Cancer warning - what colour are your toes? Hidden signs of cancer underneath your socks
CANCER symptoms vary depending on which part of the body is affected by a tumour. You could lower your risk of cancer signs by regularly checking your toes. These are the colours of toes to watch out for - it could be a sign of a deadly tumour. (Source: Daily Express - Health)
Source: Daily Express - Health - November 30, 2018 Category: Consumer Health News Source Type: news

Emulsifiers added to food may be causing cancer, new study finds
(Natural News) Emulsifiers, food additives that are used to extend shelf life and create a better food texture, may be causing colon cancer and colorectal cancer, according to a study published in the journal Cancer Research. For the study, researchers in at the Institute for Biomedical Sciences at Georgia State University fed mice with polysorbate... (Source: NaturalNews.com)
Source: NaturalNews.com - November 30, 2018 Category: Consumer Health News Source Type: news

WATCH: Teen left in tears as her classmates reveal she's cancer free
Friends, family, teachers and classmates gathered at Raytown High School in Missouri, to reveal the news. (Source: ABC News: Health)
Source: ABC News: Health - November 30, 2018 Category: Consumer Health News Tags: GMA Source Type: news

Teen left in tears as her classmates reveal she's cancer-free
A girl recently received a big surprise from her peers as they revealed the overwhelming news that she had beat cancer. (Source: ABC News: Health)
Source: ABC News: Health - November 30, 2018 Category: Consumer Health News Tags: GMA Source Type: news

US Oncology Research Announces Schedule of Presentations at the 2018 American Society of Hematology Annual Meeting and Exposition
THE WOODLANDS, TEXAS, November 30, 2018 — During the 60th American Society of Hematology (ASH) Annual Meeting and Exposition, principal investigators from The US Oncology Network and US Oncology Research will demonstrate detailed results from 18 studies (two orals, 15 poster presentations and one la... (Source: McKesson News)
Source: McKesson News - November 30, 2018 Category: Information Technology Source Type: news

Trust MRgFUS for prostate cancer ablation
MR-guided focused ultrasound (MRgFUS) is a viable tool for prostate cancer...Read more on AuntMinnie.comRelated Reading: Clinicians use MRgFUS to treat neuropathic pain MRgFUS offers less-invasive fibroid fix MRgFUS shows effectiveness for essential tremor Focused ultrasound trial for depression gets underway MRgFUS pioneer Jolesz dies (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 30, 2018 Category: Radiology Source Type: news

Inherited Lung Cancer Syndromes Targeting Never Smokers Inherited Lung Cancer Syndromes Targeting Never Smokers
Which germline mutations are associated with inherited lung cancer syndromes in never smokers?Translational Lung Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 30, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Free, publicly available health data proves to be research gold mine
(University of Calgary) Immunotherapy has become a popular treatment for some cancers. University of Calgary researchers discover how a set of genes, those associated with the extracellular matrix, had a direct connection to how cancer patients respond to immunotherapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 30, 2018 Category: Cancer & Oncology Source Type: news

Immunotherapy keeps some advanced head and neck cancer patients alive for over three years
(Institute of Cancer Research) A new immunotherapy can greatly extend the lives of a proportion of people with advanced head and neck cancer, with some living for three years or more, a major new clinical trial reports.Overall, the drug pembrolizumab had significant benefits for patients, with 37 per cent of patients who received it surviving for a year or more, compared with only 26.5 per cent of those on standard care. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 30, 2018 Category: Cancer & Oncology Source Type: news

System can rapidly and accurately detect tumor margins during breast cancer surgery
(RIKEN) Scientists from the RIKEN Cluster for Pioneering Research (CPR), Osaka University, and collaborators have developed a new rapid and inexpensive way to accurately detect the margins between cancer and non-cancerous tissue during breast surgery. Their system is noteworthy in that it can detect the morphology of the cells, differentiating between cells that are more or less dangerous. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 30, 2018 Category: Biology Source Type: news

Study: Immunotherapy better than chemotherapy for subtype of head and neck cancer
(University of California - San Diego) A randomized clinical trial involving 97 medical centers in 20 countries, including Moores Cancer Center at UC San Diego Health, found that treating patients with head and neck cancer with the immunotherapy drug pembrolizumab is more effective and less toxic than standard chemotherapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 30, 2018 Category: International Medicine & Public Health Source Type: news

St. Jude research into leukemia, sickle cell and other blood disorders presented at ASH
(St. Jude Children's Research Hospital) The 60th Annual Meeting of the American Society of Hematology will feature research from St. Jude Children's Research Hospital on topics ranging from the genomic basis and vulnerabilities of leukemia to an update on gene therapy for hemophilia B to advances in sickle cell disease and beta-thalassemia. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 30, 2018 Category: Cancer & Oncology Source Type: news

A cancer drug may help treat human papillomavirus infections
(University of Alabama at Birmingham) Preclinical experiments suggest the cancer drugs vorinostat, belinostat and panobinostat might be repurposed to treat infections caused by human papillomaviruses, or HPVs. Highly efficacious vaccines against HPV infection exist -- including the recently approved Gardasil 9, which immunizes against nine genotypes of HPV known to cause cervical, vulvar, vaginal and anal cancers. But the vaccine needs to be given before a person becomes sexually active, since it has no therapeutic efficacy against existing HPV infections. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 30, 2018 Category: Cancer & Oncology Source Type: news

App helps breast cancer survivors improve health after treatment
(Houston Methodist) Breast cancer survivors who used a smartphone app created at Houston Methodist consistently lost weight, largely due to daily, real-time interactions with their health care team via the mobile app. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 30, 2018 Category: Cancer & Oncology Source Type: news

Patients with cancer are more at risk of complications following heart procedure
(Keele University) Research led by Keele University suggests that patients with cancer who undergo a common heart procedure have worse short-term clinical outcomes compared to non-cancer patients, in the largest study undertaken to date. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 30, 2018 Category: International Medicine & Public Health Source Type: news

Can a Third-Generation ALK Inhibitor Improve Outcomes in NSCLC?
In this phase II trial, researchers tested the efficacy of lorlatinib in six expansion cohorts of NSCLC patients based on ALK mutation status and prior treatment. (Source: CancerNetwork)
Source: CancerNetwork - November 30, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Expediting 3D Analysis of Normal and Diseased Tissues
The current gold standard for tissue analysis, formalin fixation paraffin embedding (FFPE) followed by 2D thin sectioning, has been around for more than a century. And like any 100-year-old technology, it has key limitations.. So, ClearLight Biotechnologies is on a mission to significantly improve the field by automating nondestructive processing of tissue in 3D as a means to initially facilitate preclinical and clinical research applications. Laurie Goodman, PhD, CEO and board manager of ClearLight Biotechnologies, explained the process in an interview with MD+DI. ClearLight’s fou...
Source: MDDI - November 30, 2018 Category: Medical Devices Authors: Susan Shepard Tags: Imaging Source Type: news

FDA Approves Firdapse for Rare Autoimmune Disorder
First agency - sanctioned treatment for adults with Lambert - Eaton myasthenic syndrome (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 30, 2018 Category: Cancer & Oncology Tags: Neurology, Oncology, Pharmacy, Institutional, Source Type: news

FDA Warns About Serious Adverse Effect of AML Drug Enasidenib FDA Warns About Serious Adverse Effect of AML Drug Enasidenib
A life-threatening adverse effect called differentiation syndrome is not being recognized in patients receiving the acute myeloid leukemia drug enasidenib, says the FDA.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 30, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

Next-generation particle accelerators promise big benefits
A new generation of particle accelerators will help physicists explore the mysteries of the universe, provide engineers with novel tools to combat pollution and enable doctors to treat cancer more effectively. An EU-funded project is leading the advance, developing technologies that are set to have a profound impact on science and society. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - November 30, 2018 Category: Research Source Type: news

FDA Warns About Dangerous Side Effect of AML Drug Enasidenib FDA Warns About Dangerous Side Effect of AML Drug Enasidenib
A life-threatening side effect called differentiation syndrome is not being recognized in patients receiving the acute myeloid leukemia drug enasidenib, says the FDA.News Alerts (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 29, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

For Chronic Leukemia Patients, the News Just Got Even Better
Several chronic lymphocytic leukemia (CLL) patients at the Wilmot Cancer Institute took part in two groundbreaking, nationwide phase 3 studies that are changing the way doctors treat the disease. The positive results are being reported this weekend at the 2018 American Society of Hematology (ASH) annual meeting — and will immediately impact CLL patients in the Rochester region and across the U.S., said Paul Barr, M.D., director of Wilmot’s Clinical Trials Office. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - November 29, 2018 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news

Cryoablation a Promising Alternative to Surgery in Low-Risk Breast Cancer Cryoablation a Promising Alternative to Surgery in Low-Risk Breast Cancer
Image-guided cryoablation can be an effective primary treatment for small, low-risk breast tumors without lumpectomy, according to new data from the ongoing Ice 3 trial.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 29, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

An opioid epidemic may be looming in Mexico — and the U.S. may be partly responsible
This study was funded by the National Institute of Mental Health; the National Institute on Drug Abuse; a New Investigator Award from the Canadian Institutes of Health Research; an Early Researcher Award from the Ontario Ministry of Research, Innovation and Science; the UCLA Center for HIV Identification, Prevention and Treatment Services; the UCLA Center for AIDS Research; and the UCLA Clinical Translational Science Institute. (Source: UCLA Newsroom: Health Sciences)
Source: UCLA Newsroom: Health Sciences - November 29, 2018 Category: Universities & Medical Training Source Type: news

US screening data from Fukushima shed light on thyroid cancer in kids
The latest results of mass ultrasound screening of children for thyroid cancer...Read more on AuntMinnie.comRelated Reading: Article questions long-term health effects of atomic bombs Debate roils Japan over rise in children's thyroid cancer Ultrasound shows thyroid cancer spike after Fukushima Fukushima nuclear disaster casts shadow on CR images More work required to erase radiation in Fukushima (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 29, 2018 Category: Radiology Source Type: news

Getting Anticoagulation Right: New VTE Guidelines From ASH Getting Anticoagulation Right: New VTE Guidelines From ASH
ASH has released new guidelines for the management of VTE in adults, pregnant women, and children.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 29, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Image-Guided Cryoablation: an Option in Early Breast Cancer?
(MedPage Today) -- Researchers tout as potential alternative to lumpectomy in low-risk disease (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - November 29, 2018 Category: Hematology Source Type: news

Many incidental findings spotted on MRIs, few turn out to be cancer
(Reuters Health) - Many people who get magnetic resonance imaging (MRIs) for a variety of common health problems may get an unexpected cancer scare that turns out to be a false alarm, a research review suggests. (Source: Reuters: Health)
Source: Reuters: Health - November 29, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

How Useful Are Immune Checkpoint Markers in Squamous Cell Carcinoma?
A recent study examined the literature on whether immune checkpoint molecules improve overall survival in oral squamous cell carcinoma. (Source: CancerNetwork)
Source: CancerNetwork - November 29, 2018 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news

Rare cancer linked to breast implants, but Health Canada says no safety advisory is needed
At least 25 Canadian women have developed a rare cancer linked to breast implants — and almost all of them had the same type of textured implant, according to researchers. But Health Canada has no plans to remove this implant from the market or to directly alert Canadian women who have the implants, an investigation by Enquête and Radio-Canada has shown. (Source: CBC | Health)
Source: CBC | Health - November 29, 2018 Category: Consumer Health News Tags: News/Health Source Type: news

Research links rare cancer to breast implants, but Health Canada says no safety advisory is needed
At least 25 Canadian women have developed a rare cancer linked to breast implants — and almost all of them had the same type of textured implant, according to researchers. But Health Canada has no plans to remove this implant from the market or to directly alert Canadian women who have the implants, an investigation by Enquête and Radio-Canada has shown. (Source: CBC | Health)
Source: CBC | Health - November 29, 2018 Category: Consumer Health News Tags: News/Health Source Type: news

5 Things to Know About Bladder Cancer 5 Things to Know About Bladder Cancer
From new immunotherapies to the role of the microbiome in cancer pathogenesis, here are the most important recent developments in bladder cancer.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 29, 2018 Category: Consumer Health News Tags: Hematology-Oncology Article Source Type: news

Persistent Back Pain Linked to Earlier Mortality in Older Women
Those with frequent persistent back pain have higher risk for all - cause, cardiovascular, cancer mortality (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 29, 2018 Category: Cancer & Oncology Tags: Cardiology, Family Medicine, Geriatrics, Internal Medicine, Nursing, Oncology, Orthopedics, Anesthesiology & amp; Pain, Journal, Source Type: news

Liquid Biopsy Can Assess Tx Response of Peds Brain Tumors
Study is the first to document the utility of liquid biopsy in a pediatric brain tumor population (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 29, 2018 Category: Cancer & Oncology Tags: Neurology, Oncology, Pathology, Pediatrics, Journal, Source Type: news

Many US Cancer Centers Accused of Misleading Advertising Many US Cancer Centers Accused of Misleading Advertising
A consumer watchdog group says the vast majority of top-spending cancer treatment facilities use ads that highlight exceptional patient responses and mask poor survival odds.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 29, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Rebekah Vardy praised for 'open legs' smear test photo
Rebekah Vardy's photo has prompted women to have smear tests, a cervical cancer charity has said. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 29, 2018 Category: Consumer Health News Source Type: news

Cognitive Dysfunction Clues; AI for Breast Images; Treatment vs Hospice
(MedPage Today) -- News, features, and commentary about cancer-related issues (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - November 29, 2018 Category: American Health Source Type: news

A Three-Pronged Attack on Recurring Prostate Cancer A Three-Pronged Attack on Recurring Prostate Cancer
Results from the SPPORT trial seem hopeful, but are they good enough to adopt across the board?Medscape Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 29, 2018 Category: Consumer Health News Tags: Urology Commentary Source Type: news

Varian receives China NMPA approval for cancer treatment system
[Image from Varian Medical Systems]Varian has received approval from China’s National Medical Product Administration for its Halcyon system to treat cancer. The Halcyon system is designed to treat cancer patients with radiotherapy to treat lung, prostate, breast, head & neck and other forms of cancer. The system has a human-centered and user-friendly design to improve clinical workflow, accelerate installation timeframes, expedite commissioning, simplify training and automate treatment. Get the full story on our sister site Medical Design & Outsourcing. The post Varian receives China NMPA approval f...
Source: Mass Device - November 29, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Regulatory/Compliance Varian Medical Systems Source Type: news

US Life Expectency Drops; Drug Overdoses & Suicide To Blame
By Susan Scutti, CNN (CNN) — Life expectancy in the United States declined from 2016 to 2017, yet the 10 leading causes of death remained the same, according to three government reports released Thursday. Increasing deaths due to drug overdoses and suicides explain this slight downtick in life expectancy, the US Centers for Disease Control says. Overdose deaths reached a new high in 2017, topping 70,000, while the suicide rate increased by 3.7%, the CDC’s National Center for Health Statistics reports. Dr. Robert Redfield, CDC director, called the trend tragic and troubling. “Life expectancy give...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 29, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN Source Type: news

Loxo, Bayer get first FDA win with $400k rare cancer drug
A cutting-edge oncology drug developed by Loxo Oncology and Bayer has won approval in the U.S. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 29, 2018 Category: Pharmaceuticals Source Type: news

Unfinished business: An assessment of the national approach to improving cancer services in England 19952015
This report looks at progress in cancer care in England over two decades. There has been improvement on reducing mortality and the chances of survival and the experience of care, however the gap in survival rates with comparable countries has not been closed. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 29, 2018 Category: Consumer Health News Source Type: news

Wendy Atkin obituary
Epidemiologist whose research led to a breakthrough in bowel cancer screening programmes worldwide“Breakthrough” is an overused word when applied to medical advances. But in the case of the2010 trial of a new screening test for bowel cancer led by Wendy Atkin, professor of gastrointestinal epidemiology atImperial College London, who has died of acute myeloid leukaemia aged 71, it is fully deserved. Its impact will be felt by millions. The trial was the first in the world to show that bowel cancer – the second biggest cancer killer in the UK – could be prevented with a simple, five-minute test.The ex...
Source: Guardian Unlimited Science - November 29, 2018 Category: Science Authors: Ara Darzi Tags: Cancer research Health Medical research Science Source Type: news

TRACON Pharmaceuticals and I-Mab Biopharma Announce Strategic Partnerships for Multiple Immuno-Oncology Programs
I-Mab's Broad and Innovative Pipeline to Leverage TRACON's U.S. Product Development Solution Platform SHANGHAI, Nov. 29, 2018 -- (Healthcare Sales & Marketing Network) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical compan... Biopharmaceuticals, Oncology I-Mab Biopharma, TRACON Pharmaceuticals, immuno-oncology (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 29, 2018 Category: Pharmaceuticals Source Type: news

It Looked Like a Beer Belly. It Turned Out He Had a 77-Pound Tumor.
As his stomach grew and the rest of his body got thinner, Hector Hernandez knew something was wrong, but he never suspected it was cancer. (Source: NYT Health)
Source: NYT Health - November 29, 2018 Category: Consumer Health News Authors: CHRISTINA CARON Tags: Tumors Hector Hernandez Downey (Calif) Surgery and Surgeons William Tseng University of Southern California Cancer Source Type: news